MXPA04007186A - Nuevos derivados de la piridazina, su utilizacion como medicamentos, composiciones farmaceuticas y su procedimiento de preparacion. - Google Patents
Nuevos derivados de la piridazina, su utilizacion como medicamentos, composiciones farmaceuticas y su procedimiento de preparacion.Info
- Publication number
- MXPA04007186A MXPA04007186A MXPA04007186A MXPA04007186A MXPA04007186A MX PA04007186 A MXPA04007186 A MX PA04007186A MX PA04007186 A MXPA04007186 A MX PA04007186A MX PA04007186 A MXPA04007186 A MX PA04007186A MX PA04007186 A MXPA04007186 A MX PA04007186A
- Authority
- MX
- Mexico
- Prior art keywords
- radical
- same
- medicaments
- producing
- pharmaceutical compositions
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000004892 pyridazines Chemical class 0.000 title 1
- 150000003254 radicals Chemical group 0.000 abstract 4
- -1 COOR Chemical group 0.000 abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000005840 aryl radicals Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0201632A FR2835835B1 (fr) | 2002-02-11 | 2002-02-11 | Nouveaux derives de la pyridazine, leur utilisation comme medicaments, compositions pharmaceutiques et leur procede de preparation |
| PCT/FR2003/000381 WO2003068140A2 (fr) | 2002-02-11 | 2003-02-07 | Derives de la pyridazine, leur utilisation comme medicaments, et leur procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04007186A true MXPA04007186A (es) | 2004-10-29 |
Family
ID=27620073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04007186A MXPA04007186A (es) | 2002-02-11 | 2003-02-07 | Nuevos derivados de la piridazina, su utilizacion como medicamentos, composiciones farmaceuticas y su procedimiento de preparacion. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7223758B2 (OSRAM) |
| EP (1) | EP1476434B1 (OSRAM) |
| JP (1) | JP4447324B2 (OSRAM) |
| AT (1) | ATE329907T1 (OSRAM) |
| AU (1) | AU2003222363A1 (OSRAM) |
| BR (1) | BR0307565A (OSRAM) |
| CA (1) | CA2475439A1 (OSRAM) |
| CY (1) | CY1107483T1 (OSRAM) |
| DE (1) | DE60306122T2 (OSRAM) |
| DK (1) | DK1476434T3 (OSRAM) |
| ES (1) | ES2266806T3 (OSRAM) |
| FR (1) | FR2835835B1 (OSRAM) |
| MX (1) | MXPA04007186A (OSRAM) |
| PT (1) | PT1476434E (OSRAM) |
| WO (1) | WO2003068140A2 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2839309B1 (fr) * | 2002-05-03 | 2004-07-23 | Aventis Pharma Sa | Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation |
| JP2008531503A (ja) * | 2005-02-23 | 2008-08-14 | スミスクライン ビーチャム コーポレーション | グルココルチコイド受容体のモジュレーターとしてのナフタレン誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ112694A3 (en) * | 1991-11-08 | 1994-12-15 | Sankyo Co | Derivatives of piperizinecarboxylic acids and process for preparing thereof |
-
2002
- 2002-02-11 FR FR0201632A patent/FR2835835B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-07 DE DE60306122T patent/DE60306122T2/de not_active Expired - Lifetime
- 2003-02-07 AU AU2003222363A patent/AU2003222363A1/en not_active Abandoned
- 2003-02-07 MX MXPA04007186A patent/MXPA04007186A/es unknown
- 2003-02-07 PT PT03717380T patent/PT1476434E/pt unknown
- 2003-02-07 BR BR0307565-6A patent/BR0307565A/pt not_active IP Right Cessation
- 2003-02-07 EP EP03717380A patent/EP1476434B1/fr not_active Expired - Lifetime
- 2003-02-07 AT AT03717380T patent/ATE329907T1/de active
- 2003-02-07 WO PCT/FR2003/000381 patent/WO2003068140A2/fr not_active Ceased
- 2003-02-07 JP JP2003567325A patent/JP4447324B2/ja not_active Expired - Fee Related
- 2003-02-07 CA CA002475439A patent/CA2475439A1/fr not_active Abandoned
- 2003-02-07 ES ES03717380T patent/ES2266806T3/es not_active Expired - Lifetime
- 2003-02-07 DK DK03717380T patent/DK1476434T3/da active
-
2004
- 2004-08-11 US US10/916,175 patent/US7223758B2/en not_active Expired - Lifetime
-
2006
- 2006-09-07 CY CY20061101281T patent/CY1107483T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2475439A1 (fr) | 2003-08-21 |
| ES2266806T3 (es) | 2007-03-01 |
| BR0307565A (pt) | 2004-12-21 |
| EP1476434B1 (fr) | 2006-06-14 |
| PT1476434E (pt) | 2006-10-31 |
| DE60306122D1 (de) | 2006-07-27 |
| DK1476434T3 (da) | 2006-10-16 |
| US20050165017A1 (en) | 2005-07-28 |
| AU2003222363A1 (en) | 2003-09-04 |
| WO2003068140A3 (fr) | 2004-04-08 |
| CY1107483T1 (el) | 2013-03-13 |
| JP4447324B2 (ja) | 2010-04-07 |
| FR2835835A1 (fr) | 2003-08-15 |
| WO2003068140A2 (fr) | 2003-08-21 |
| DE60306122T2 (de) | 2007-06-06 |
| ATE329907T1 (de) | 2006-07-15 |
| EP1476434A2 (fr) | 2004-11-17 |
| JP2005525334A (ja) | 2005-08-25 |
| US7223758B2 (en) | 2007-05-29 |
| FR2835835B1 (fr) | 2004-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0402376A2 (hu) | Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények | |
| DE60305514D1 (de) | Neue verwendung von benzothiazolderivaten | |
| DE60019904D1 (de) | Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen | |
| NZ536734A (en) | Spiroindolinepiperidine derivatives | |
| MXPA05001581A (es) | Algunas imidazopiridinas novedosas y su uso. | |
| BG108806A (en) | IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF | |
| MXPA04000577A (es) | Derivados de dolastatina 10. | |
| TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
| GB9202791D0 (en) | Compounds | |
| DE3767839D1 (de) | Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten. | |
| UA48937C2 (uk) | Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить | |
| TW200510311A (en) | CCr8 inhibitors | |
| AU6500298A (en) | Derivatives of azetidine and pyrrolidine | |
| EP1483251A4 (en) | DERIVATIVES OF C3-CYANO EPOTHILONE | |
| MY133527A (en) | Isoquinoline derivatives | |
| PE20040750A1 (es) | Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3 | |
| NZ524742A (en) | Bridged piperazine derivatives | |
| ATE239711T1 (de) | Neue allythiopyridazinderivate und verfahren zu ihrer herstellung | |
| MXPA05014068A (es) | Dicetopiperazinas sustituidas y su uso como antagonistas de oxitocina. | |
| WO2003068140A3 (fr) | Derives de la pyridazine, leur utilisation comme medicaments, et leur procede de preparation | |
| AU695907B2 (en) | Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases | |
| BG106520A (en) | Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity | |
| MXPA05013225A (es) | Derivados de 1-aril-4-(ariloxicarbonil)-piperazina para uso como inhibidores de la lipasa sensible a hormonas. | |
| MXPA06004307A (es) | Derivados de benzazepina como inhibidores de mao-b. | |
| GB0208176D0 (en) | Organic compounds |